Xencor Inc (XNCR): Broker Consensus Forecast

The XNCR stock price trend on the GURU.Markets platform, currently at 42.59, illustrates the dynamics of the business of profiting from licenses for a unique antibody development system. Experienced management is wisely investing in primary research, but global political fragmentation and trade barriers significantly hinder cross-border logistics and scientific exchange in the field of oncology.

XNCR xencor.com: Price Target Chart in the range 07/04/2022 - 11/11/2026

Metric breakdowns and analytics for Xencor Corp (XNCR)

- stock price and consensus target price:

Share Price xencor.com|XNCR - Price Target Chart

- stock exchange capitalization data:

Market Capitalization Xencor Corp|XNCR - Enterprise Value

- business book valuation details:

Accounting Value per Share Xencor|XNCR - Company Book Value|Market Value to Book Value xencor.com|XNCR - Aggregate Company Assets

- debt obligations and liquidity statistics:

- business earnings and investment ratios data:

XNCR - Company Net Income|Expected Net Profit Xencor, Inc.|XNCR - P/E Multiple|Forward Price to Earnings Multiple Xencor Inc|XNCR - Price/Earnings to Growth Multiple|Company Value to EBITDA Xencor Corp|XNCR - Operating profit before deduction of amortization|Earnings per share for the trailing year Xencor|XNCR - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months xencor.com|XNCR - Earnings per share growth in current year|Expected earnings per share growth for next year Xencor, Inc.

General company analysis:XNCR (xencor.com)

Geopolitical risks are limiting the international clinical trials and patent protection of Xencor, Inc. (XNCR). Under these conditions, the consensus share value based on forecasts reflects the arithmetic mean of expert expectations regarding the asset's future price. The upward trend of the line confirms market confidence in the success of oncology therapy despite external barriers. However, a sharp spike in the indicator may signal that the business is overvalued, which directly impacts the final market capitalization.

Competitors of Xencor, Inc.